Intrathecal monoclonal antibody therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intrathecal monoclonal antibody therapy, covering 2016-11-22 to 2016-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis [Phase 2]